Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-007921
Filing Date
2016-08-11
Accepted
2016-08-11 16:35:58
Documents
46
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zyne-20160630x10q.htm 10-Q 786696
2 EX-31.1 zyne-20160630ex311e1bcbc.htm EX-31.1 10314
3 EX-31.2 zyne-20160630ex312555819.htm EX-31.2 10194
4 EX-32.1 zyne-20160630ex3216f3e36.htm EX-32.1 6362
5 EX-32.2 zyne-20160630ex322d06ba5.htm EX-32.2 6373
  Complete submission text file 0001558370-16-007921.txt   3151653

Data Files

Seq Description Document Type Size
6 EX-101.INS zyne-20160630.xml EX-101.INS 649947
7 EX-101.SCH zyne-20160630.xsd EX-101.SCH 22395
8 EX-101.CAL zyne-20160630_cal.xml EX-101.CAL 28839
9 EX-101.DEF zyne-20160630_def.xml EX-101.DEF 83841
10 EX-101.LAB zyne-20160630_lab.xml EX-101.LAB 213750
11 EX-101.PRE zyne-20160630_pre.xml EX-101.PRE 174508
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

EIN.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37526 | Film No.: 161825089
SIC: 2834 Pharmaceutical Preparations